Thierry Trenque

1.6k total citations
75 papers, 1.0k citations indexed

About

Thierry Trenque is a scholar working on Pharmacology, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thierry Trenque has authored 75 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 17 papers in Toxicology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thierry Trenque's work include Pharmacovigilance and Adverse Drug Reactions (16 papers), Drug-Induced Adverse Reactions (11 papers) and Pharmaceutical Practices and Patient Outcomes (7 papers). Thierry Trenque is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (16 papers), Drug-Induced Adverse Reactions (11 papers) and Pharmaceutical Practices and Patient Outcomes (7 papers). Thierry Trenque collaborates with scholars based in France, United States and New Zealand. Thierry Trenque's co-authors include Hervé Millart, Denis Lamiable, Moustapha Dramé, Guillaume Hoizey, Lukshe Kanagaratnam, Matthieu L. Kaltenbach, Damien Jolly, Rachid Mahmoudi, Jean‐Luc Novella and Paul de Boissieu and has published in prestigious journals such as Journal of Clinical Microbiology, Clinical Chemistry and Journal of the American Academy of Dermatology.

In The Last Decade

Thierry Trenque

74 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Trenque France 18 180 153 124 119 104 75 1.0k
Luis H. Martín Arias Spain 14 171 0.9× 174 1.1× 72 0.6× 111 0.9× 87 0.8× 59 965
Harmeet Singh Rehan India 18 127 0.7× 206 1.3× 113 0.9× 201 1.7× 59 0.6× 64 964
Alberto Vaccheri Italy 25 260 1.4× 195 1.3× 139 1.1× 124 1.0× 141 1.4× 74 1.5k
Thor Hilberg Norway 14 141 0.8× 327 2.1× 225 1.8× 124 1.0× 60 0.6× 26 842
Alessandro Ceschi Switzerland 22 205 1.1× 164 1.1× 103 0.8× 110 0.9× 80 0.8× 94 1.5k
Francesco Rossi Italy 23 287 1.6× 146 1.0× 51 0.4× 161 1.4× 103 1.0× 112 1.7k
Olivia Leoni Italy 16 103 0.6× 133 0.9× 83 0.7× 82 0.7× 93 0.9× 82 753
Gillian Pearce United Kingdom 16 161 0.9× 97 0.6× 51 0.4× 114 1.0× 114 1.1× 28 967
William G. Troutman United States 26 236 1.3× 178 1.2× 70 0.6× 165 1.4× 64 0.6× 43 1.7k
Élisabeth Polard France 19 163 0.9× 44 0.3× 91 0.7× 107 0.9× 123 1.2× 75 1.1k

Countries citing papers authored by Thierry Trenque

Since Specialization
Citations

This map shows the geographic impact of Thierry Trenque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Trenque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Trenque more than expected).

Fields of papers citing papers by Thierry Trenque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Trenque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Trenque. The network helps show where Thierry Trenque may publish in the future.

Co-authorship network of co-authors of Thierry Trenque

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Trenque. A scholar is included among the top collaborators of Thierry Trenque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Trenque. Thierry Trenque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trenque, Thierry, et al.. (2023). Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapies. 79(3). 365–370. 2 indexed citations
2.
Trenque, Thierry, et al.. (2023). Drug‐induced Sweet's syndrome: A case/non‐case study in the French pharmacovigilance database. British Journal of Clinical Pharmacology. 90(8). 1873–1879. 4 indexed citations
3.
Charmillon, Alexandre, Xavier Parent, Simona Pavel, et al.. (2022). Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study. EClinicalMedicine. 45. 101340–101340. 9 indexed citations
4.
Robinson, James C., et al.. (2021). Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals. Therapies. 77(4). 467–475. 11 indexed citations
5.
Boissieu, Paul de, et al.. (2017). Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. European Journal of Clinical Pharmacology. 73(5). 517–523. 7 indexed citations
6.
Kanagaratnam, Lukshe, Moustapha Dramé, Jean‐Luc Novella, et al.. (2016). Risk Factors for Adverse Drug Reactions in Older Subjects Hospitalized in a Dedicated Dementia Unit. American Journal of Geriatric Psychiatry. 25(3). 290–296. 13 indexed citations
7.
Kanagaratnam, Lukshe, et al.. (2016). Les effets indésirables médicamenteux en pédiatrie : expérience d’un centre régional de pharmacovigilance. Therapies. 71(5). 467–473. 4 indexed citations
8.
Boissieu, Paul de, et al.. (2015). Drug-induced hallucination: a case/non case study in the French Pharmacovigilance Database. The European Journal of Psychiatry. 29(1). 21–31. 11 indexed citations
9.
Kanagaratnam, Lukshe, et al.. (2015). Les effets indésirables médicamenteux graves et leur évitabilité chez des sujets âgés de plus de 65 ans. Therapies. 70(5). 477–484. 4 indexed citations
10.
Boissieu, Paul de & Thierry Trenque. (2015). Standardized classification unsuitable for spontaneous reporting: the example of osteonecrosis of the jaw. Expert Opinion on Drug Safety. 14(7). 1015–1021. 1 indexed citations
11.
Trenque, Thierry, et al.. (2014). Methylphenidate off-label use and safety. SpringerPlus. 3(1). 286–286. 23 indexed citations
13.
Narbey, D., Damien Jolly, Rachid Mahmoudi, et al.. (2013). Relationship between anticholinergic drug use and one-year outcome among elderly people hospitalised in medical wards via emergency department: The safes cohort study. The journal of nutrition health & aging. 17(9). 766–771. 5 indexed citations
14.
Trenque, Thierry, et al.. (2008). Hallucinations et rêves sous propofol. Therapies. 63(2). 141–144. 5 indexed citations
15.
Kelly, William N., Félix Arellano, Joanne Barnes, et al.. (2007). Guidelines for Submitting Adverse Event Reports for Publication. Drug Safety. 30(5). 367–373. 89 indexed citations
16.
Trenque, Thierry, Nicolas Simon, Isabelle Villena, et al.. (2004). Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. British Journal of Clinical Pharmacology. 57(6). 735–741. 26 indexed citations
17.
Trenque, Thierry, et al.. (2003). Hyperprolactinémies d’origine médicamenteuse : étude cas/non-cas dans la banque nationale de pharmacovigilance. Therapies. 58(2). 159–163. 19 indexed citations
18.
Hoizey, Guillaume, Pierre‐François Souchon, Thierry Trenque, et al.. (2002). An Unusual Case of Methyl Bromide Poisoning. Journal of Toxicology Clinical Toxicology. 40(6). 817–821. 4 indexed citations
19.
Trenque, Thierry, et al.. (1996). Drug points: Pravastatin: interaction with oral anticoagulant?. BMJ. 312(7035). 886.3–886.3. 14 indexed citations
20.
Lamiable, Denis, et al.. (1993). Sensitive high-performance liquid chromatographic method for the determination of coumarin in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 620(2). 273–277. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026